Powder Delivery TRIZ Cases

Daily oral liquid edaravone maintains bioavailability while removing infusion visits and drug-free periods in neurodegenerative treatment.

AI and LiDAR cut 2D-to-3D mesh generation from minutes of post-processing to under 5 ms while adding quantum-resistant asset security.

Covalent phosphate nanodiscs protect nucleic acid therapeutics from degradation and endosomal entrapment, improving cytoplasmic delivery at lower doses.

Gold nanoparticles bind thiolated double-stranded DNA to improve nuclear delivery and antigen expression while avoiding plasmid-related side effects.

Water-soluble viscous additives keep fluorescent particles evenly dispersed, preventing concentration gradients and needle blockage during tumor marking.

Lactobacillus plantarum strains modulate gut microbiota to counteract stress-related behavioral, biochemical, and cognitive effects.

Multiple VHH domains engage DR5 receptors simultaneously, while buffered formulations preserve polypeptide activity and limit aggregation.

Phospholipids and bile salts form aqueous mixed micelles that solubilize water-insoluble vitamins while improving stability without organic solvents.

Polymer nanoparticles deliver therapeutic genes to target tissues, enabling sustained full-length antibody expression and prolonged persistence.

Guide RNA and Cas components create SERPINA1 breaks to reduce mutant AAT while preserving wild-type lung protection.

Low aqueous solubility and systemic toxicity challenge therapeutic agents; tetra-aza corand cavities encapsulate them for controlled delivery.

Mesoporous magnesium carbonate confines amorphous API in 2–10 nm pores, enhancing solubility and storage stability.

Controlled teverelix-to-TFA ratios produce a homogeneous, injectable microcrystalline suspension after reconstitution.

Polyalkyleneimine complexes protect poly(I:C) from RNase degradation while improving homogeneity, cellular uptake, and pharmacokinetic consistency.

Peptide-linked alginate gels chelate radionuclide cations and retain them in the gel network for selective radiotherapy.

Combines methylene blue and aspirin in a dissolvable powder or pill to address viral replication, inflammation, and lingering COVID-19 symptoms.

Vertical housing adjustment and an inward-outward catheter arm support precise positioning, while transparent shielding blocks beta radiation.

A capsule-based dry powder formulation increases treprostinil dosing flexibility for pulmonary hypertension without nebulization.

Optimized mannitol, sucrose, and glycine excipients help high-concentration lyophilized biologics reconstitute quickly while preserving stability.

A removable jumper links inflow and outflow conduits for faster priming, lower air-introduction risk, and reduced radioactive microsphere dropout.

A miniemulsion forms peptide cores inside biodegradable polymer shells, preserving SHG/THG signals in aqueous suspension.

Aerosolized PDE5 powder bypasses oral first-pass metabolism to improve lung delivery while limiting systemic side effects.

Fc fusion and pH 6–8 buffering help stabilize a long-acting IL-2 analog conjugate during storage while reducing treatment toxicity.

Resin-complexed Valaciclovir masks bitterness in a reconstituted pediatric suspension while supporting stability and bioavailability.

A polymer-based solid dispersion improves oral bioavailability of a substituted indane HIF-2α inhibitor for disease treatment.

Refractory seizure treatments can fail or act briefly; this injectable ganaxolone complex improves aqueous solubility and supports rapid blood levels.

Lipid nanoparticles deliver guide RNAs and base editors into hepatocytes, offering an alternative to donor-limited liver transplantation for TTR amyloidosis.

Nitrogen-base salts raise Foxy-5 solubility, while thermocycling improves stability for higher production throughput.

Colloidal gold nanoparticles bind TNFα and IFNγ for tumor-targeted cytokine delivery, helping preserve potency while limiting organ side effects.

Alanine, trehalose, glycylglycine, polysorbate 20, and DTPA help stabilize IL-12-ABD fusion proteins in liquid and solid formulations.

Controlled pre-freezing, sublimation, and vacuum conditions stabilize aminolevulinic acid hydrochloride while limiting moisture and impurities.

To treat IBD without broad immunosuppression, antigen-MHC nanoparticles target gut microbial antigens and amplify anti-inflammatory T cells.

Cholesterol acts as a penetration enhancer so topical statins cross the skin barrier and inhibit CTGF and collagen expression linked to scarring.

Oxidation and degradation threaten active content; this case uses sodium-salt lyophilization to maintain stability without extraneous stabilizers.

Trehalose, sucrose, and ascorbic acid stabilize GRP targeting conjugates against radiolysis in a lyophilized kit for room-temperature storage.

An intranasal powder combines dihydroergotamine with excipients to prolong Tmax, lower metabolite Cmax, and limit receptor binding.

Cross-linked cyclic macromolecule nanoparticles address poor HDACi solubility and clearance with up to 30% loading and 21-day release.

A defined peptide sequence stimulates glycosaminoglycan, collagen, and aggrecan production to support hyaline cartilage regeneration.

Cyclodextrin inclusion complexes improve imidazolinone dissolution and formulation stability while preserving DNA-PK inhibitory activity.

Inhalation delivery of glycopyrrolate addresses tachycardia risk while providing heart-rate lowering for up to 30 hours.

One-pot addition and controlled pH adjustment reduce foaming, lumps, and oligomer formation in scalable GLP-2 liquid formulations.

Trehalose-stabilized lyophilization preserves adjuvant particle structure and vaccine potency across wider storage temperatures.

Glycocalyx-selective nanoparticle probes use surface properties and shear-related binding to distinguish healthy from non-healthy cells earlier.

Weaning dietary shifts destabilize pig gut microbiomes; isolated probiotic strains help limit pathogen entry and improve growth and feed efficiency.

Poor insulin solubility and dose uniformity are addressed with discrete particles that dissolve rapidly in infant nutrition.

The process targets 3–5% residual moisture through controlled low-temperature secondary drying, helping prevent product collapse and degradation during storage.

Defined peptide sequences stimulate glycosaminoglycan, collagen, and aggrecan production to support durable cartilage regeneration without surgery.

Surgical repair can leave incision scars and weakly durable fibrocartilage; this peptide stimulates cartilage matrix formation.

Acetate or histidine buffers plus sugars, sodium chloride, and surfactants help stabilize high-concentration IL-17A antibody formulations.